The Pharmacogenomics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Pharmacogenomics Market?
The size of the pharmacogenomics market has recently experienced significant expansion. It is projected to increase from $8.94 billion in 2024 to $9.92 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Pharmacogenomics Industry?
The Pharmacogenomics Global Market is projected to reach a value of $14.81 billion in 2029, growing at a compound annual growth rate (CAGR) of 10.5%.
Download Your Free Sample of the 2025 Pharmacogenomics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Pharmacogenomics Market?
The key drivers in the pharmacogenomics market are:
• Rising aging population and surge in chronic diseases
• Growing demand for cancer treatment
• Efforts towards integration of artificial intelligence in genomics
• Development and application of new techniques like 3D genomics, metagenomics and psychotropic pharmacogenomics.
Global Market Segmentation: Identifying Major Pharmacogenomics Industry Segments
The pharmacogenomics market covered in this report is segmented –
1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies
2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications
3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users
Pre-order the 2025 Pharmacogenomics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Pharmacogenomics Market?
The key trends in the pharmacogenomics market are:
• There is a growing trend towards the use of genome editing solutions for the analysis of advanced therapies.
• Integration of artificial intelligence in genomics for genetic data analysis is garnering increasing attention.
• Advancements in metagenomics and strategic partnerships are notably shaping the market.
• The introduction of three-dimensional genomics (which study influences on gene expression and function), along with product innovations focusing on infectious diseases and gene editing, is an emerging trend.
Who Are the Top Competitors & Leading Players in the Pharmacogenomics Market?
Major companies in the pharmacogenomics market are:
• Illumina Inc
• Eurofins Scientific
• Myriad Genetics Inc
• PerkinElmer Inc
• Centogene N.V
• Invitae Corporation
• Genomind
• Pacific Biosciences of California Inc
• Oneome LLC
• Admera Health
• MapMyGenome
• Positive Bioscience
• Xcode Life Sciences
• Xcelris Labs
• Takeda Pharmaceutical Company Limited
• Garvan Institute of Medical Research
• 3D Medicines Inc
• Berry Genomics
• BGI
• GenomiCare Biotechnology
• Bayer AG
• GlaxoSmithKline plc (GSK)
• F Hoffmann-La Roche AG
• Merck KGaA
• QIAGEN N.V
• Centro de Genoma e Biologia de Sistemas (CGBS)
• Dasa Group
• Datar Cancer Genetics Limited
• MedGenome Labs
• 23andMe
• Color Genomics
• Pathway Genomics
• Laboratório Richet
• Laboratório Exame
• Genomika Diagnósticos
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the pharmacogenomics market in 2024
